Your browser doesn't support javascript.
loading
DPP-4 Inhibitor Teneligliptin Improves Insulin Resistance and Serum Lipid Profile in Japanese Patients with Type 2 Diabetes.
Kusunoki, M; Sato, D; Nakamura, T; Oshida, Y; Tsutsui, H; Natsume, Y; Tsutsumi, K; Miyata, T.
Afiliación
  • Kusunoki M; Department of Internal Medicine, Medical Clinic, Aichi Medical University, Nagoya, Japan.
  • Sato D; Department of Biomedical Information Engineering, Graduate School of Medical Science, Yamagata University, Yamagata, Japan.
  • Nakamura T; Department of Biomedical Information Engineering, Graduate School of Medical Science, Yamagata University, Yamagata, Japan.
  • Oshida Y; Research Center of Health, Physical Fitness and Sports, Nagoya University, Nagoya, Japan.
  • Tsutsui H; Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan.
  • Natsume Y; Department of Sports Medicine, Graduate School of Medicine, Nagoya University, Nagoya, Japan.
  • Tsutsumi K; Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
  • Miyata T; Vascular Center, Sanno Medical Center, Tokyo, Japan.
Drug Res (Stuttg) ; 65(10): 532-4, 2015 Oct.
Article en En | MEDLINE | ID: mdl-25368904
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirazoles / Resistencia a la Insulina / Diabetes Mellitus Tipo 2 / Tiazolidinas / Lípidos Tipo de estudio: Observational_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirazoles / Resistencia a la Insulina / Diabetes Mellitus Tipo 2 / Tiazolidinas / Lípidos Tipo de estudio: Observational_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2015 Tipo del documento: Article